Andere Sprachen Adaptive Biotechnologies Corporation

Aktien

A2PLR5

US00650F1093

ADPT

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 24.04.2024			% 5 Tage	% 1. Jan.
2.6 ^USD	+0.78%		+6.56%	-46.94%

02.04.	Adaptive Biotechnologies meldet vorläufigen Q1-Umsatz und ernennt Kyle Piskel zum CFO	MT
02.04.	Transcript : Adaptive Biotechnologies Corporation - Special Call

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024	17.04.
Adaptive Biotechnologies Corporation Announces Preliminary Unaudited Revenue Results for the First Quarter Ended March 31, 2024	05.04.
Adaptive Biotechnologies Corporation Announces CFO Changes	03.04.
Adaptive Biotechnologies Reports Preliminary Q1 Revenue, Appoints Kyle Piskel as CFO	02.04.
Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue	02.04.
Adaptive Biotechnologies Corporation Provides Revenue Guidance for the First Quarter Ended March 31, 2024	02.04.
Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024	27.03.
Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024	27.03.
Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference	22.02.
Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference	22.02.
Adaptive Biotechnologies' Q4 Loss Widens; Revenue Declines; Shares Down	15.02.
Adaptive Biotechnologies: Q4 Earnings Snapshot	14.02.
Earnings Flash (ADPT) ADAPTIVE BIOTECHNOLOGIES Reports Q4 Revenue $45.8M, vs. Street Est of $48.5M	14.02.
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results	14.02.
Adaptive Biotechnologies Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	14.02.
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024	29.01.
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024	29.01.
Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference	27.12.
Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference	27.12.
Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in Patients with Blood Cancers at the 65th ASH Annual Meeting	09.12.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Adaptive Biotechnologies Corporation

Aktien

A2PLR5

US00650F1093

ADPT

Andere Sprachen

Filter